DE602004027367D1 - Chinazolinonderivate und deren verwendung zur herstellung von pharmazeutischen zusammensetzungen mit parp-inhibierender wirkung - Google Patents
Chinazolinonderivate und deren verwendung zur herstellung von pharmazeutischen zusammensetzungen mit parp-inhibierender wirkungInfo
- Publication number
- DE602004027367D1 DE602004027367D1 DE602004027367T DE602004027367T DE602004027367D1 DE 602004027367 D1 DE602004027367 D1 DE 602004027367D1 DE 602004027367 T DE602004027367 T DE 602004027367T DE 602004027367 T DE602004027367 T DE 602004027367T DE 602004027367 D1 DE602004027367 D1 DE 602004027367D1
- Authority
- DE
- Germany
- Prior art keywords
- parp
- preparation
- hydrogen
- general formula
- pharmaceutical compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 102000012338 Poly(ADP-ribose) Polymerases Human genes 0.000 abstract 2
- 108010061844 Poly(ADP-ribose) Polymerases Proteins 0.000 abstract 2
- 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0301173A HU227948B1 (en) | 2003-04-30 | 2003-04-30 | Quinazoline derivatives and their use for the preparation of pharmaceutical compositions inhibiting parp enzyme |
| PCT/HU2004/000044 WO2004096779A1 (en) | 2003-04-30 | 2004-04-30 | Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004027367D1 true DE602004027367D1 (de) | 2010-07-08 |
Family
ID=89981336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004027367T Expired - Lifetime DE602004027367D1 (de) | 2003-04-30 | 2004-04-30 | Chinazolinonderivate und deren verwendung zur herstellung von pharmazeutischen zusammensetzungen mit parp-inhibierender wirkung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7994182B2 (de) |
| EP (1) | EP1622881B1 (de) |
| AT (1) | ATE469133T1 (de) |
| DE (1) | DE602004027367D1 (de) |
| ES (1) | ES2346438T3 (de) |
| HU (1) | HU227948B1 (de) |
| PL (1) | PL1622881T3 (de) |
| SI (1) | SI1622881T1 (de) |
| WO (1) | WO2004096779A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011058367A2 (en) | 2009-11-13 | 2011-05-19 | Astrazeneca Ab | Diagnostic test for predicting responsiveness to treatment with poly(adp-ribose) polymerase (parp) inhibitor |
| RU2013114710A (ru) | 2010-09-03 | 2014-10-10 | Байер Интеллектуэль Проперти Гмбх | Замещенные конденсированные пиримидиноны и дигидропиримидиноны |
| CN103130723B (zh) | 2011-11-30 | 2015-01-14 | 成都地奥制药集团有限公司 | 一种多聚(adp-核糖)聚合酶抑制剂 |
| EP3325623B3 (de) | 2015-07-23 | 2021-01-20 | Institut Curie | Verwendung einer kombination aus dbait-molekül und parp-inhibitoren zur behandlung von krebs |
| GB201519573D0 (en) | 2015-11-05 | 2015-12-23 | King S College London | Combination |
| CN106083741A (zh) * | 2016-02-22 | 2016-11-09 | 南京中医药大学 | 2‑硫代喹唑啉二酮衍生物 |
| WO2018162439A1 (en) | 2017-03-08 | 2018-09-13 | Onxeo | New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule |
| WO2018197461A1 (en) | 2017-04-28 | 2018-11-01 | Akribes Biomedical Gmbh | A parp inhibitor in combination with a glucocorticoid and/or ascorbic acid and/or a protein growth factor for the treatment of impaired wound healing |
| WO2019175132A1 (en) | 2018-03-13 | 2019-09-19 | Onxeo | A dbait molecule against acquired resistance in the treatment of cancer |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3073826A (en) | 1960-10-20 | 1963-01-15 | Mead Johnson & Co | 3-pyrrolidylmethyl-4-quinazolones |
| JPH07107056B2 (ja) * | 1987-01-30 | 1995-11-15 | 日清製粉株式会社 | ４（３ｈ）−キナゾリノン誘導体、その製造方法およびそれを有効成分とする抗潰瘍剤 |
| US20020022636A1 (en) | 1997-09-03 | 2002-02-21 | Jia-He Li | Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| AUPR201600A0 (en) | 2000-12-11 | 2001-01-11 | Fujisawa Pharmaceutical Co., Ltd. | Quinazolinone derivative |
| WO2002094790A1 (fr) | 2001-05-23 | 2002-11-28 | Mitsubishi Pharma Corporation | Compose heterocyclique condense et son utilisation medicale |
-
2003
- 2003-04-30 HU HU0301173A patent/HU227948B1/hu not_active IP Right Cessation
-
2004
- 2004-04-30 EP EP04730604A patent/EP1622881B1/de not_active Expired - Lifetime
- 2004-04-30 ES ES04730604T patent/ES2346438T3/es not_active Expired - Lifetime
- 2004-04-30 WO PCT/HU2004/000044 patent/WO2004096779A1/en active Application Filing
- 2004-04-30 PL PL04730604T patent/PL1622881T3/pl unknown
- 2004-04-30 SI SI200431482T patent/SI1622881T1/sl unknown
- 2004-04-30 AT AT04730604T patent/ATE469133T1/de active
- 2004-04-30 US US10/554,749 patent/US7994182B2/en not_active Expired - Fee Related
- 2004-04-30 DE DE602004027367T patent/DE602004027367D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| SI1622881T1 (sl) | 2010-09-30 |
| HUP0301173A2 (en) | 2007-09-28 |
| ES2346438T3 (es) | 2010-10-15 |
| HUP0301173A3 (en) | 2008-08-28 |
| PL1622881T3 (pl) | 2010-10-29 |
| ATE469133T1 (de) | 2010-06-15 |
| HU0301173D0 (en) | 2003-07-28 |
| EP1622881A1 (de) | 2006-02-08 |
| US7994182B2 (en) | 2011-08-09 |
| EP1622881B1 (de) | 2010-05-26 |
| HU227948B1 (en) | 2012-07-30 |
| US20070042935A1 (en) | 2007-02-22 |
| WO2004096779A1 (en) | 2004-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1666A (en) | Quinolinone derivatives as tyrosine kinase inhibitors. | |
| ATE402174T1 (de) | Imidazopyridinderivate als kinaseinhibitoren | |
| WO2006084017A3 (en) | Phenyl-substituted pyrimidine compounds useful as kinase inhibitors | |
| NO20056010L (no) | Biaryloksymetylaren-karboksylsyrer | |
| NO20051263L (no) | Ny anvendelse av benzotiazolderivater | |
| DE60238042D1 (de) | Glycyrrhetinsäurederivate und ihre verwendung zur herstellung eines medikaments zur hemmung der 11-beta-hydroxysteroid dehydrogenase | |
| SE0202462D0 (sv) | Novel use | |
| NO20022201L (no) | Lösninger inneholdende Epinastin | |
| DE602004027367D1 (de) | Chinazolinonderivate und deren verwendung zur herstellung von pharmazeutischen zusammensetzungen mit parp-inhibierender wirkung | |
| SE9701304D0 (sv) | Compounds | |
| DE602006009556D1 (de) | Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen | |
| ATE391730T1 (de) | Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung | |
| DE60328819D1 (de) | Indol-3-carboxamide, deren herstellung und therapeutische verwendung | |
| DE69903053D1 (de) | Diaminocyclobuten-3,4-dionderivate, deren herstellung und deren verwendung | |
| WO2003066594A3 (de) | 3-alkanoylamino-propionsäure-derivate als inhibitoren des integrins avss6 | |
| MXPA02004441A (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa. | |
| SE0300105D0 (sv) | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof | |
| DE60210981D1 (de) | Heteroarylheteroalkylamin derivate und deren verwendung als inhibitoren der stickoxidsynthase | |
| EA200700208A1 (ru) | Новая псевдополиморфная форма деслоратадина, образованная с диоксидом углерода | |
| BRPI0417140A (pt) | derivados quinolina ácidos e seu uso na prevenção e/ou tratamento de patologias relacionadas com hiperglicemia | |
| ATE288910T1 (de) | Substituierte alkylaminopyridazinonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| DE502004010108D1 (de) | Carbonylamino-substituierte acyl-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung | |
| SE0400285D0 (sv) | Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof | |
| EA201170268A1 (ru) | Соединения с серотонинергической активностью, способ их получения и содержащие их фармацевтические композиции | |
| SE9902596D0 (sv) | Pharmaceutically active compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |